CTOs on the Move

Belong.Life

www.belong.life

 
Belong is the world`s largest digital social network for cancer patients and caregivers.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Belong.Life raised $14M on 07/01/2019

Similar Companies

Memorial Healthcare System

Since its inception more than 55 years ago, Memorial Healthcare System has been a leader in providing high-quality healthcare services to South Florida residents. Today, it is the fifth-largest public healthcare system in the nation and highly regarded for its exceptional patient- and family-centered care. Memorial`s patient, physician and employee satisfaction rates are some of the most admired in the country, and the system is recognized as a national leader in quality care. To be a premier clinically integrated delivery system providing access to exceptional patient-and family-centered care, medical education, research and innovation for the benefit of the community we serve.

Kootenai Prosthetics and Orthotics

Kootenai Prosthetics and Orthotics is a Coeur D Alene, ID-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Biolegend

Biolegend is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in San Diego, CA. To find more information about Biolegend, please visit www.biolegend.com

BCN Risk Management and Workers' Compensation

BCN Risk Management and Workers' Compensation is a Reno, NV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

RaNA Therapeutics

RaNA Therapeutics is pioneering the discovery of a new class of RNA-targeted medicines that selectively activate protein expression within the body`s own cells. By targeting specific genes, RaNA`s novel drugs work epigenetically to precisely upregulate the expression of beneficial proteins in order to treat or prevent disease. The company`s leadership leverages preeminent founders and advisors in the field, and the strength of its fundamental patents, technology, and know-how that underlie the discovery and development of therapeutics that selectively activate RNA. RaNA is applying its proprietary technology to rapidly advance a pipeline of novel drugs for diverse therapeutic areas, with an initial emphasis in the fields of rare genetic disorders, inflammation, oncology, metabolic diseases and neurodegenerative diseases.